ÌÇÐÄÆƽâ°æ

As of Q4 2025, U.S. company Amgen reported over three million U.S. dollars in sales per employee for the trailing twelve months, among the selected U.S.-based biotech and drug companies. Neurocrine Biosciences followed this with sales per employee of two million U.S. dollars.